• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿白蛋白在预测非瓣膜性心房颤动患者血栓栓塞事件中的价值。

The value of urine albumin in predicting thromboembolic events for patients with non-valvular atrial fibrillation.

作者信息

He Haohui, Guo Jun, Zhang Aidong

机构信息

Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.

Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.

出版信息

Int J Cardiol. 2016 Oct 15;221:827-30. doi: 10.1016/j.ijcard.2016.07.145. Epub 2016 Jul 11.

DOI:10.1016/j.ijcard.2016.07.145
PMID:27434352
Abstract

BACKGROUND

Accurate risk stratification is important in the management of patients with non-valvular atrial fibrillation (NVAF). However, one cohort study demonstrated an annual ischemic stroke rate of 1.61% in the group of patients classified in "the true low risk" according to CHA2DS2-VASc. We aimed to find out more indicators and evaluate their abilities in predicting thromboembolic events (TE).

METHODS

We assigned 58 patients with TE to the thrombosis group, and 157 patients without TE to the non-thrombosis group. The clinical parameters of these patients were subjected to univariate analysis and unconditioned logistic regression analysis for screening the risk factor, which was urine albumin (UA) according to the result. The receiver operating characteristic (ROC) curve was used to determine the optimal cut-off point of the UA. Then we formed the CHA2DS2-VASc-UA2 score and made a comparison with CHA2DS2-VASc score.

RESULTS

Mean UA of the thrombosis group was significantly higher than that of the non-thrombosis group (0.1g/L vs 0.0g/L, P<0.01). The results of unconditioned logistic regression analysis showed that OR of UA was 40.98 (95% CI: 3.58-468.88, P<0.01). The Area Under the Curve (AUC) of UA was 0.700 with an optimal cut-off point of 0.03g/L. ROC curve analysis result showed that AUC of CHA2DS2-VASc-UA2 score was larger than that of CHA2DS2-VASc score (0.873 vs 0.860, P<0.01).

CONCLUSION

UA≥0.03g/L is the independent predictive factor of TE for NVAF patients. And the CHA2DS2-VASc-UA2 score might perform better in predicting TE compared with the CHA2DS2-VASc score.

摘要

背景

准确的风险分层对于非瓣膜性心房颤动(NVAF)患者的管理至关重要。然而,一项队列研究表明,根据CHA2DS2-VASc分类为“真正低风险”的患者组中,年度缺血性卒中发生率为1.61%。我们旨在找出更多指标并评估它们预测血栓栓塞事件(TE)的能力。

方法

我们将58例发生TE的患者分配到血栓形成组,将157例未发生TE的患者分配到非血栓形成组。对这些患者的临床参数进行单因素分析和非条件逻辑回归分析以筛选危险因素,根据结果该危险因素为尿白蛋白(UA)。采用受试者工作特征(ROC)曲线确定UA的最佳截断点。然后我们构建了CHA2DS2-VASc-UA2评分,并与CHA2DS2-VASc评分进行比较。

结果

血栓形成组的平均UA显著高于非血栓形成组(0.1g/L对0.0g/L,P<0.01)。非条件逻辑回归分析结果显示,UA的比值比(OR)为40.98(95%置信区间:3.58-468.88,P<0.01)。UA的曲线下面积(AUC)为0.700,最佳截断点为0.03g/L。ROC曲线分析结果显示,CHA2DS2-VASc-UA2评分的AUC大于CHA2DS2-VASc评分(0.873对0.860,P<0.01)。

结论

UA≥0.03g/L是NVAF患者TE的独立预测因素。并且与CHA2DS2-VASc评分相比,CHA2DS2-VASc-UA2评分在预测TE方面可能表现更好。

相似文献

1
The value of urine albumin in predicting thromboembolic events for patients with non-valvular atrial fibrillation.尿白蛋白在预测非瓣膜性心房颤动患者血栓栓塞事件中的价值。
Int J Cardiol. 2016 Oct 15;221:827-30. doi: 10.1016/j.ijcard.2016.07.145. Epub 2016 Jul 11.
2
Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score.CHA2DS2-VASc评分低的非瓣膜性心房颤动患者发生血栓栓塞的危险因素。
Medicine (Baltimore). 2019 Feb;98(8):e14549. doi: 10.1097/MD.0000000000014549.
3
Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation.CHA2DS2-VASc与新的R2CHADS2及ATRIA评分在预测非抗凝和抗凝的非瓣膜性心房颤动患者血栓栓塞事件方面的比较。
BMC Cardiovasc Disord. 2015 Nov 19;15:156. doi: 10.1186/s12872-015-0149-3.
4
Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.CHADS2与CHA2DS2-VASc对心房颤动患者独立于抗凝治疗的中风和血栓栓塞预测的荟萃分析。
Tex Heart Inst J. 2015 Feb 1;42(1):6-15. doi: 10.14503/THIJ-14-4353. eCollection 2015 Feb.
5
R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.R2CHADS2 评分与 CHA2DS2-VASc 评分在房颤导管消融术后血栓栓塞事件中的比较。
Can J Cardiol. 2014 Apr;30(4):405-12. doi: 10.1016/j.cjca.2014.01.005. Epub 2014 Jan 13.
6
Meta-analysis of ATRIA versus CHADS-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation.用于预测心房颤动患者中风和血栓栓塞的 ATRIA 与 CHADS-VASc 的荟萃分析。
Int J Cardiol. 2017 Jan 15;227:436-442. doi: 10.1016/j.ijcard.2016.11.015. Epub 2016 Nov 9.
7
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.肾功能障碍、卒中风险评分(CHADS2、CHA2DS2-VASc 和 R2CHADS2)与心房颤动导管消融术后血栓栓塞事件风险:莱比锡心脏中心房颤消融登记研究。
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.
8
Relation of red blood cell distribution width with CHADS and CHADS-VASc score in Chinese patients with non-valvular atrial fibrillation.中国非瓣膜性心房颤动患者红细胞分布宽度与CHADS及CHADS-VASc评分的关系
Int J Cardiol. 2017 Feb 1;228:861-864. doi: 10.1016/j.ijcard.2016.11.255. Epub 2016 Nov 14.
9
External validation and comparison of CHADS-VASc-RAF and CHADS-VASc-LAF scores for predicting left atrial thrombus and spontaneous echo contrast in patients with non-valvular atrial fibrillation.非瓣膜性心房颤动患者左心房血栓和自发性回声对比中 CHADS-VASc-RAF 和 CHADS-VASc-LAF 评分的外部验证和比较。
J Interv Card Electrophysiol. 2022 Nov;65(2):535-542. doi: 10.1007/s10840-022-01285-y. Epub 2022 Jul 13.
10
CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.CHADS2 和 CHA2DS2-VASc 评分作为预测阵发性心房颤动左心房消融结局的指标。
Europace. 2014 Feb;16(2):202-7. doi: 10.1093/europace/eut210. Epub 2013 Jun 28.

引用本文的文献

1
Combined Predictive Value of Neutrophil-to-Lymphocyte Ratio and CHA2DS2-VASc Score for Cardiogenic Cerebral Embolism in NVAF Patients.中性粒细胞与淋巴细胞比值和CHA2DS2-VASc评分对非瓣膜性房颤患者心源性脑栓塞的联合预测价值
Int J Gen Med. 2025 Jun 27;18:3489-3499. doi: 10.2147/IJGM.S523480. eCollection 2025.
2
Prevalence of albuminuria and its association with left atrial remodelling in patients with atrial fibrillation.心房颤动患者中蛋白尿的患病率及其与左心房重构的关联
Eur Heart J Open. 2025 May 14;5(3):oeaf054. doi: 10.1093/ehjopen/oeaf054. eCollection 2025 May.
3
Left atrial enlargement and high uric acid level are risk factors for left atrial thrombus or dense spontaneous echo contrast in atrial fibrillation patients with low to moderate embolic risk assessed by CHADS-VAS score.
通过CHADS-VAS评分评估为低至中度栓塞风险的房颤患者中,左心房扩大和高尿酸水平是左心房血栓或密集自发显影对比的危险因素。
Front Cardiovasc Med. 2023 Jul 3;10:937770. doi: 10.3389/fcvm.2023.937770. eCollection 2023.
4
Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation.综合比较中风风险评分表现:6267728 例房颤患者的系统评价和荟萃分析。
Europace. 2022 Nov 22;24(11):1739-1753. doi: 10.1093/europace/euac096.
5
A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.非瓣膜性心房颤动患者缺血性卒中评估生物标志物综述
Front Cardiovasc Med. 2021 Jul 1;8:682538. doi: 10.3389/fcvm.2021.682538. eCollection 2021.
6
Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies.心房颤动患者的卒中与出血风险评估:概念与争议
Front Med (Lausanne). 2020 Feb 21;7:54. doi: 10.3389/fmed.2020.00054. eCollection 2020.